|
|
???tair.name??? >
???browser.page.title.author???
|
"yang ss"???jsp.browse.items-by-author.description???
Showing items 11-35 of 68 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
|
Lee, SW; Lee, TY; Cheng, YC; Yen, CL; Yang, SS |
| 中山醫學大學 |
2021 |
Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor
|
Liao, TL; Chen, YM; Hsieh, SL; Tang, KT; Chen, DY; Yang, YY; Liu, HJ; Yang, SS |
| 中山醫學大學 |
2021 |
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease
|
Tsai, HJ; Chuang, YW; Yang, SS; Chang, YZ; Chang, HR; Lee, TY |
| 中山醫學大學 |
2021 |
Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
|
Lai, CY; Yang, SS; Lee, SW; Tsai, HJ; Lee, TY |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 中山醫學大學 |
2020 |
The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma
|
Lee, SW; Lee, TY; Peng, YC; Yang, SS; Yeh, HZ; Chang, CS |
| 中山醫學大學 |
2020 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Yang, SS; Peng, CY; Lin, WT; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang, WY; Chiu, YC; Chiu, FW; Hsu, YC; Tseng, TC; Cheng, PN; Yang, SS; Liu, CJ; Su, TH; Yang, HC; Liu, CH; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
|
Hsu, SJ; Yang, SS; Kao, JH |
| 中山醫學大學 |
2020 |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu, CH; Peng, CY; Fang, YJ; Kao, WY; Yang, SS; Lin, CK; Lai, HC; Su, WP; Fang, SU; Chang, CC; Su, TH; Liu, CJ; Chen, PJ; Chen, DS; Kao, JH |
| 國立臺灣海洋大學 |
2017-06 |
Differential synchrotron X-ray imaging markers based on the renal microvasculature for tubulointerstitial lesions and glomerulopathy.
|
Ka SM; Lin YC; Hwu Y; Huang GS; Hsiao M; Lee TT; Yang SM; Lee TK; Chen NY; Yang SS; Chen A |
| 國立交通大學 |
2014-12-08T15:44:52Z |
Poly(2,3-diphenylphenylene vinylene) derivatives having liquid crystalline side groups
|
Li, AK; Yang, SS; Jean, WY; Hsu, CS; Hsieh, BR |
| 臺北醫學大學 |
2014 |
Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new onset diabetes: A nationwide cohort study
|
Huang, YW;Yang, SS;Fu, SC;Wang, TC;Hsu, CK;Chen, DS;Hu, JT;Kao, JH |
| 臺北醫學大學 |
2014 |
Reduced Toll-like receptor-9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
Huang, YW;Hsu, CK;Lin, SC;Wei, SC;Hu, JT;Chang, HY;Liang, CW;Chen, DS;Chen, PJ;Hsu, PN;Yang, SS;Kao, JH |
| 臺北醫學大學 |
2014 |
On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogues therapy
|
Huang, YW;Takahashi, S;Tsuge, M;Chen, CL;Wang, TC;Abe, H;Hu, JT;Chen, DS;Yang, SS;Chayama, K;Kao, JH |
| 臺北醫學大學 |
2014 |
Detectability and clinical significance of serum hepatitis B virus ribonucleic acid
|
Huang, YW;Chayama, K;Kao, JH;Yang, SS |
| 臺北醫學大學 |
2014 |
Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients
|
Huang, YW;Yang, SS;Kao, JH |
| 臺北醫學大學 |
2013 |
Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study
|
Huang, YW;Wang, TC;Lin, SC;Yang, SS;Chen, DS;Hu, JT;Kao, JH |
| 臺北醫學大學 |
2013 |
Reduced Toll-like receptor-3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
Huang, YW;Lin, SC;Wei, SC;Hu, JT;Chang, HY;Huang, SH;Chen, DS;Chen, PJ;Hsu, PN;Yang, SS;Kao, JH |
| 臺北醫學大學 |
2013 |
Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients
|
Huang, YW;Hu, JT;Hu, FC;Chang, CJ;Chang, HY;Kao, JH;Yang, SS;Chen, DS |
| 高雄醫學大學 |
2011 |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving
|
曾岱宗;余明隆;劉俊人;林志陵;許景盛;劉振樺;楊賢馨;蘇建維;陳培哲;陳定信;高嘉宏. ; Tseng TC;Yu ML;Liu CJ;Lin CL;Huang YW;Hsu CS;Liu CH;Kuo SF;Pan CJ;Yang SS;Su CW;Chen PJ;Chen DS;Kao JH. |
| 臺北醫學大學 |
2009 |
New Constituents with iNOS Inhibitory Activity from mycelium of Antrodia camphorata.
|
李宗徽; Yang SS; Wang GJ; Wang SY; Lin YY; Kuo YH; Lee TH |
| 高雄醫學大學 |
2009 |
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
|
張美惠;陳定信;莊萬龍; Chang MH;You SL;Chen CJ;Liu CJ;Lee CM;Lin SM;Chu HC;Wu TC;Yang SS;Kuo HS;Chen DS;Chuang WL;etal. |
| 國立臺灣大學 |
2008-11 |
Peginterferon alfa-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial
|
Liu, CH; Liu, CJ; Lin, CL; Liang, CC; Hsu, SJ; Yang, SS; Hsu, CS; Tseng, TC; Wang, CC; Lai, MY; Chen, JH; Chen, PJ; Chen, DS; Kao, JH |
Showing items 11-35 of 68 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
